Literature DB >> 36131193

Unmet Need in People with Psoriasis and Skin of Color in Canada and the United States.

Geeta Yadav1,2,3, Jensen Yeung1,3,4,5, Yvette Miller-Monthrope1,3, Omair Lakhani6, Christopher Drudge7, Samantha Craigie7, Ari Mendell7, Laura Park-Wyllie8.   

Abstract

The experience of dermatological conditions such as psoriasis is different for people with skin of color (SoC) than for white individuals. The objective of this literature review was to understand challenges and unmet needs associated with access to care, diagnosis, and treatment of psoriasis among people with SoC in Canada and the United States. The review focused on studies published in the last 5 years. After screening 919 unique records, 26 studies were included. Importantly, lack of culturally competent care was identified as a key unmet need for psoriasis among people with SoC. In addition, cost of care and cultural views of psoriasis may influence decisions to seek care among people with SoC. Baseline patient characteristics in psoriasis studies and the prevalence/incidence of psoriasis vary across racial/ethnic groups, which may reflect differences in the rate and/or timing of diagnosis. The presentation of psoriasis differs across racial/ethnic groups, which may contribute to challenges in proper and timely diagnosis. Compared with white patients with psoriasis, individuals with SoC may be less familiar with and have different rates of treatment with biologic therapies for psoriasis, are more likely to be hospitalized for psoriasis, and their access to physicians may differ. Further, people with SoC are underrepresented in clinical trials of psoriasis therapies. Overall, the results of this literature review suggest that people with psoriasis and SoC face unique challenges in their disease experience. It is essential that clinicians and other stakeholders recognize and address these disparities to ensure equitable care.
© 2022. The Author(s).

Entities:  

Keywords:  Access to care; Diagnosis; Health equity; Psoriasis; Skin of color; Treatment; Unmet need

Year:  2022        PMID: 36131193     DOI: 10.1007/s13555-022-00811-0

Source DB:  PubMed          Journal:  Dermatol Ther (Heidelb)


  39 in total

1.  Prevalence of psoriasis among adults in the US 2009-2010 and 2013-2014 National Health and Nutrition Examination Surveys.

Authors:  Jeffrey Liu; Akshitha Thatiparthi; Amylee Martin; Alexander Egeberg; Jashin J Wu
Journal:  J Am Acad Dermatol       Date:  2020-10-23       Impact factor: 11.527

2.  Biologics utilization for psoriasis is lower in black compared with white patients.

Authors:  W T Hodges; T Bhat; N S Raval; C Herbosa; P Ugwu-Dike; S G Kwatra; A Musiek; C Mann; Y R Semenov
Journal:  Br J Dermatol       Date:  2021-04-18       Impact factor: 9.302

3.  Equally inequitable? A cross-national comparative study of racial health inequalities in the United States and Canada.

Authors:  Chantel Ramraj; Faraz Vahid Shahidi; William Darity; Ichiro Kawachi; Daniyal Zuberi; Arjumand Siddiqi
Journal:  Soc Sci Med       Date:  2016-05-18       Impact factor: 4.634

4.  The inpatient burden of psoriasis in the United States.

Authors:  Derek Y Hsu; Kenneth Gordon; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2016-05-20       Impact factor: 11.527

Review 5.  Psoriatic Disease in the US Latino Population: A Comprehensive Review.

Authors:  Alyssa Gwen Ashbaugh; Chloe Ekelem; Yessica Landaverde; Natasha Atanaskova Mesinkovska
Journal:  Am J Clin Dermatol       Date:  2020-04       Impact factor: 7.403

6.  The State of Ethnic Dermatology in Canada.

Authors:  Boluwaji Ogunyemi; Yvette Miller-Monthrope
Journal:  J Cutan Med Surg       Date:  2017 Sep/Oct       Impact factor: 2.092

7.  Top dermatologic conditions in patients of color: an analysis of nationally representative data.

Authors:  Scott A Davis; Swetha Narahari; Steven R Feldman; William Huang; Rita O Pichardo-Geisinger; Amy J McMichael
Journal:  J Drugs Dermatol       Date:  2012-04       Impact factor: 2.114

8.  Incidence of psoriasis among adults in the United States: A sex- and age-adjusted population analysis.

Authors:  Joshua Burshtein; Andrew Strunk; Amit Garg
Journal:  J Am Acad Dermatol       Date:  2020-11-27       Impact factor: 11.527

9.  US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

Authors:  Mark G Lebwohl; Arthur Kavanaugh; April W Armstrong; Abby S Van Voorhees
Journal:  Am J Clin Dermatol       Date:  2016-02       Impact factor: 7.403

10.  Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn's disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis.

Authors:  Susan C Bolge; Helen M Eldridge; Jennifer H Lofland; Caitlin Ravin; Philip J Hart; Michael P Ingham
Journal:  Patient Prefer Adherence       Date:  2017-03-28       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.